Journey Medical Corp (NAS:DERM)
$ 5.67 -0.26 (-4.33%) Market Cap: 117.52 Mil Enterprise Value: 120.26 Mil PE Ratio: 0 PB Ratio: 10.64 GF Score: 33/100

Q2 2024 Journey Medical Corp Earnings Call Transcript

Aug 12, 2024 / 08:30PM GMT
Release Date Price: $4.22 (-15.26%)
Operator

Good day, and welcome to Journey Medical second-quarter 2024 financial results and corporate update conference call. (Operator instructions) Participants on this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of this call will be available approximately one hour after the end of the call for approximately 30 days.

I would like to turn the conference over to Ms. Jaclyn Jaffe, the company's Senior Director of Corporate Operations. Please go ahead, ma'am.

Jaclyn Jaffe
Journey Medical Corporation - Investor Relations

Good afternoon, and thank you for participating in today's conference call. Joining me from Journey Medical's leadership team are Claude Maraoui, Co-founder, President and Chief Executive Officer; Joseph Benesch, Chief Financial Officer; Dr. Srinivas Sidgiddi, Vice President of Research and Development; and Ramsey Alloush, General Counsel and Corporate Secretary, who will be joining for the Q&A portion of the call.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot